Technology 125 of 266
Bioprocessing
4 EIC Accelerator winners build on Bioprocessing, 0% of the classified companies, in 1 sector and 2 industries.
4
Companies
1
Sectors
2
Industries
3
Countries
0%
Exits
25%
Show signs of scaling
Sectors
- Health4 (100%)
Industries
Used together with
Other technologies of the same companies
Companies per year of first award
2019
2020
2021
2022
2023
2024
- Bioprocessing
Show the numbers
| Companies | Bioprocessing | |
|---|---|---|
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 2 | 2 |
| 2022 | 2 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
What happened to them (4 of 4 checked)
- Active4 (100%)
- Exit0 (0%)
- Failed0 (0%)
- Other0 (0%)
Signs of scaling
- Scaling1 (25%)
- Not scaling2 (50%)
- Scaling unclear1 (25%)
Countries
All 4 companies using Bioprocessing
| Company | Project | Industry | Country | Cut-off | Funding | Status | Rasph |
|---|---|---|---|---|---|---|---|
| ALKION BIOINNOVATIONS | AlkaBurst2.0AlkaBurst2.0 – A game changing bioreactor for sustainable production of active pharmaceutical ingredients in a consistent, traceable and low cost approach | Biopharmaceuticals | France | March 2022 | Blended finance | Active | Deep dive |
| Cellevate AB | SBMP-microcarrierSBMP - disrupting the manufacturing of biological drugs through a ground-breaking nanotechnology-based microcarrier | Life science tools | Sweden | March 2022, October 2025 | Blended finance | Active | Deep dive |
| Fibriant B.V | RECOFIBA unique commercially viable recombinant manufacturing platform for human fibrinogen (rhFib) & thrombin (rhThr | Biopharmaceuticals | Netherlands | October 2021 | Blended finance | Active | Deep dive |
| EVerZom SAS | ACROBATToward democratisation of extracellular vesicles-based therapies | Biopharmaceuticals | France | June 2021 | Grant first | Active | Deep dive |